(VIGL) Vigil Neuroscience - Performance 79.9% in 12m
VIGL performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-43.71%
#60 in Peer-Group
Rel. Strength
92.68%
#558 in Stock-Universe
Total Return 12m
79.86%
#17 in Peer-Group
Total Return 5y
-37.87%
#52 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 7.93 USD |
| 52 Week Low | 1.40 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 87.89 |
| Buy/Sell Signal +-5 | -0.04 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: VIGL (79.9%) vs XBI (-10.8%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
9.2% | 80.8% | 81.6% | 23 | 13.8 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-8.02% | -1.47% | 149% | 12.9 | 12 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
10.1% | 2.09% | 57% | 26.2 | 13.8 | 0.96 | 0.60% | 41% |
| BIM PA Biomerieux |
3.05% | 33.4% | 9.65% | 32.6 | 25.6 | 1.54 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
6.43% | -8.71% | 7.86% | 42.4 | 24.4 | 0.27 | 18.7% | -34.3% |
| PTCT NASDAQ PTC Therapeutics |
10.5% | 38.9% | 4.12% | 7.86 | 6.36 | 0.81 | - | 68% |
| KMDA NASDAQ Kamada |
-0.15% | 37.3% | -12% | 24.6 | 20.4 | 0.81 | 48.1% | 3.93% |
| ERF PA Eurofins Scientific SE |
9.39% | 16% | 11.2% | 28.1 | 14.3 | 0.59 | -62.1% | -19.3% |
Performance Comparison: VIGL vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for VIGL
| Total Return (including Dividends) | VIGL | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 211.90% | 7.80% | 1.73% |
| 3 Months | 272.51% | -2.75% | 8.59% |
| 12 Months | 79.86% | -10.76% | 11.46% |
| 5 Years | -37.87% | -18.55% | 109.12% |
| Trend Score (consistency of price movement) | VIGL | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 31.5% | 84.2% | 69.9% |
| 3 Months | 79.2% | -2.8% | 69.3% |
| 12 Months | -48.2% | -77.8% | 43.2% |
| 5 Years | -67.1% | -53.5% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #2 | 189.33% | 206.60% |
| 3 Month | #3 | 283.05% | 243.04% |
| 12 Month | #17 | 101.55% | 61.37% |
| 5 Years | #54 | -23.58% | -53.71% |
FAQs
Does Vigil Neuroscience (VIGL) outperform the market?
Yes,
over the last 12 months VIGL made 79.86%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.76%.
Over the last 3 months VIGL made 272.51%, while XBI made -2.75%.
Performance Comparison VIGL vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
VIGL vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 0.1% | 210.2% | 295.5% | 68% |
| US NASDAQ 100 | QQQ | 0.3% | 209.7% | 295.3% | 69% |
| German DAX 40 | DAX | 3% | 212.5% | 280.2% | 52% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 0.1% | 212.8% | 295.1% | 67% |
| Hongkong Hang Seng | HSI | -1.3% | 206.2% | 278.7% | 53% |
| India NIFTY 50 | INDA | 1.3% | 211.8% | 297% | 80% |
| Brasil Bovespa | EWZ | -1.8% | 212.6% | 278.4% | 72% |
VIGL vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 0.8% | 209.5% | 292.8% | 56% |
| Consumer Discretionary | XLY | -0% | 213.5% | 304.6% | 61% |
| Consumer Staples | XLP | 0.6% | 210.6% | 295% | 72% |
| Energy | XLE | -5.9% | 209.2% | 294.6% | 77% |
| Financial | XLF | 2.3% | 214.1% | 293.3% | 55% |
| Health Care | XLV | -1.6% | 208.7% | 297.6% | 85% |
| Industrial | XLI | 1.3% | 210.9% | 290.3% | 62% |
| Materials | XLB | 0.2% | 210.4% | 296.1% | 81% |
| Real Estate | XLRE | -0.3% | 210% | 295.5% | 67% |
| Technology | XLK | -0.6% | 209.1% | 294.6% | 74% |
| Utilities | XLU | -0.5% | 209.7% | 288.5% | 60% |
| Aerospace & Defense | XAR | 0% | 203.8% | 276.9% | 38% |
| Biotech | XBI | 0.5% | 204.1% | 305.5% | 91% |
| Homebuilder | XHB | 0.7% | 218.8% | 312.2% | 90% |
| Retail | XRT | 3.6% | 210.8% | 303.6% | 79% |
VIGL vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -12.6% | 197% | 287% | 74% |
| Natural Gas | UNG | 4.5% | 222% | 280% | 99% |
| Gold | GLD | -3.9% | 206.3% | 265.5% | 31% |
| Silver | SLV | -1.1% | 201.7% | 276.2% | 55% |
| Copper | CPER | 1.3% | 210.7% | 281% | 72% |
VIGL vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -1.4% | 211% | 297.1% | 84% |
| iShares High Yield Corp. Bond | HYG | -0.3% | 211.6% | 292.1% | 71% |